植皮伤口的临床试验
总计78501个结果
-
Abramson Cancer Center of the University of Pennsylvania完全的造血干细胞移植 | 移植物抗宿主病
-
National Institute of Arthritis and Musculoskeletal...终止
-
Universitat Internacional de Catalunya招聘中
-
The Korean Society of Hematopoietic Stem Cell TransplantationHoffmann-La Roche未知
-
Pontificia Universidad Catolica de ChileHospital del Salvador; SymbiOx Inc.完全的
-
Dana-Farber Cancer Institute招聘中
-
Hospital Authority, Hong KongNovartis Pharmaceuticals; The Hong Kong Blood Cancer Foundation未知
-
National Heart, Lung, and Blood Institute (NHLBI)招聘中
-
Washington University School of MedicineCellect Biotechnology终止
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI)完全的
-
Swedish Orphan BiovitrumPRA Health Sciences; Cromsource; BioMérieux; Q2 Solutions; Cytel Inc.; ABF Pharmaceutical Services GmbH终止
-
Swedish Orphan BiovitrumPRA Health Sciences; BioMérieux; Cytel Inc.终止
-
Hadassah Medical Organization完全的
-
Joseph AntinMiltenyi Biomedicine GmbH不再可用
-
National Institute of Nursing Research (NINR)Fred Hutchinson Cancer Center终止
-
Baylor College of MedicineThe Methodist Hospital Research Institute终止
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)终止
-
Shanghai General Hospital, Shanghai Jiao Tong University...未知
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的
-
Colorado Blood Cancer Institute未知
-
St. Olavs HospitalOslo University Hospital; Norwegian University of Science and Technology完全的
-
Hospital Universitario Dr. Jose E. Gonzalez招聘中
-
University of California, San Francisco完全的
-
Oncoimmune, Inc., a subsidiary of Merck & Co.,...National Cancer Institute (NCI); University of Michigan Rogel Cancer Center; Ohio State University 和其他合作者完全的Efprezimod Alfa (CD24Fc, MK-7110) 用于预防清髓性同种异体造血干细胞移植 (HSCT) 后急性移植物抗宿主病 (GVHD) 的 II 期试验 (MK-7110-002)白血病 | 造血干细胞移植 | 移植物抗宿主病美国
-
Children's Hospital Medical Center, Cincinnati终止